SAN MATEO, Calif.–(BUSINESS WIRE)–A California federal jury on Friday, April 3, 2015 awarded Cave Consulting Group, Inc. more than $12 million after determining that UnitedHealth Group’s subsidiary OptumInsight infringed Cave Consulting Group’s patent for measuring physician efficiency. The jury also rejected OptumInsight’s counterclaim that Cave Consulting Group infringed OptumInsight’s patent for processing medical claims data. Cave Consulting Group’s U.S. Patent No. 7,739,126 (the “‘126 patent”) protects its advanced approach to analyzing physician efficiency, which enables health plans, physician groups and others to obtain accurate and reliable physician efficiency scores—increasingly vital statistical measures used to combat rising healthcare costs. CCGroup’s patented physician efficiency method is considered the de facto standard for determining physician efficiency in the healthcare industry today.
SAN MATEO, Calif.–(BUSINESS WIRE)–CCGroup is pleased to announce that it has prevailed on many of the patent infringement claims asserted against it by OptumInsight (formerly Ingenix, Inc.). OptumInsight’s claims of infringement for 6 of its 8 asserted patents, which pertained to grouping medical claims data into episode treatment groups (“ETGs”), have been dismissed by the court and cannot be reasserted. “OptumInsight has acknowledged that CCGroup has prevailed against the Symmetry ETG portfolio of patents,” stated Dr. Douglas G. Cave, President of CCGroup. Two OptumInsight patents, which expire next year, remain in suit. For the same reasons OptumInsight has dismissed a majority of its patent claims, CCGroup is confident that it will prevail on OptumInsight’s remaining claims asserted against the Cave Grouper™.
U.S. Patents Issued to Protect Cave Consulting Group’s (“CCGroup”) Physician Efficiency Measurement Using Episodes-of-Care and a Predefined Set of Medical Conditions
San Mateo, CA. – CCGroup is pleased to announce that the United States Patent and Trademark Office has issued a fourth patent to CCGroup, protecting its physician efficiency methodology and system. The four (4) patents are U.S. Patent Nos. 7,739,126; 8,301,464; 8,340,981; and 8,639,528, the most recently issued. Other patent applications are awaiting approval. Continue reading
SAN MATEO, Calif.–(BUSINESS WIRE)–CCGroup is pleased to announce that Virginia Mason Medical Center (Virginia Mason) in Seattle, Wash. continues to practice in the appropriate Clinical MedMarker™ Protocol Range for utilizing MRI of Spine in diagnostics for routine, non-complicated low back pain (LBP) patient episodes-of-care.
This news is not surprising to Robert Mecklenburg, MD, Medical Director of the Center for Healthcare Solutions at Virginia Mason. “In 2005, the medical center pursued efficiency in its spine clinic by adopting systems engineering methods of Toyota Motor Corp. As we published in the Wall Street Journal in 2007, back pain patients now follow a more standardized path. They have an initial combined visit with a physical therapist and a doctor,” Dr. Mecklenburg said. “We developed evidence-based decision rules and embedded them in the scheduling process for radiology. If the provider could not document the evidence-based indication for the imaging study on the scheduling screen, then the test could not be ordered.” He continued, “Within a year, the imaging rate of MRI of Spine decreased 23% across the enterprise.” Continue reading
San Mateo, CA. – CCGroup is pleased to announce that the company has developed an acceptable clinical protocol range for utilizing MRI of Spine in diagnostics for routine, non-complicated low back pain (LBP) patient episodes-of-care. CCGroup BullsEye™ statistical analysis and methodologies (protected by U.S. Patent No. 8,301,464) strongly correlates MRI of Spine as the key diagnostic service to orthopedists’ efficiency score in treating non-complicated LBP. Therefore, MRI of Spine is the MedMarker™ (or correlated service) in treating non-complicated LBP. Continue reading
Cave Consulting Group (“CCGroup”) Develops Acceptable Clinical Protocol Range for Upper GI Endoscopy Use in Treating Gastroesophageal (GERD)
February 22, 2013
San Mateo, CA. – CCGroup is pleased to announce that the company has developed an acceptable clinical protocol range for utilizing upper gastrointestinal (GI) endoscopies in treating routine, noncomplicated GERD (or heartburn) patient episodes-of-care. CCGroup BullsEye™ statistical analysis and methodologies (protected by U.S. Patent No. 8,301,464) strongly correlates upper GI endoscopies as the key procedure to gastroenterologists’ efficiency score in treating noncomplicated GERD. Therefore, upper GI endoscopy is the MedMarker™ (or correlated service) in treating non-complicated GERD. Continue reading
San Mateo, CA. – CCGroup is pleased to announce that the United States Patent and Trademark Office has issued Patent No. 7,739,126 on its grouper of medical condition episodes of care and provider efficiency methodology and system. “The main advantage of our patent is that the efficiency methods allow our health plan and physician group clients to obtain accurate and reliable efficiency scores, something that has been very elusive to date,” stated Douglas G. Cave, Ph.D., President of CCGroup. Continue reading
Cave Consulting Group (“CCGroup”) Receives Patent on MedMarkers™ to Support Healthcare Provider Efficiency Scores
CCGroup is pleased to announce that the United States Patent and Trademark Office has issued Patent No. 8,301,464 on its CCGroup BullsEye™ methods of statistical analysis. The CCGroup BullsEye™ system targets those medical care services most associated with provider overall efficiency scores and provider medical condition-specific efficiency scores. Continue reading